Colgate-Palmolive (NYSE:CL) Price Target Cut to $95.00 by Analysts at JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) had its price objective lowered by stock analysts at JPMorgan Chase & Co. from $99.00 to $95.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 1.91% from the stock’s previous close.

Several other brokerages have also commented on CL. Wells Fargo & Company raised their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a research note on Wednesday, April 2nd. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Friday, April 4th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. UBS Group lowered their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Finally, Stifel Nicolaus reduced their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $101.83.

Colgate-Palmolive Trading Up 1.5 %

Shares of CL stock traded up $1.42 during trading hours on Friday, reaching $93.22. 1,615,426 shares of the stock were exchanged, compared to its average volume of 5,272,993. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The firm has a market capitalization of $75.61 billion, a price-to-earnings ratio of 26.48, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company’s 50-day moving average price is $90.33 and its 200-day moving average price is $92.72.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the company posted $0.87 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive announced that its board has approved a share buyback plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 6.8% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s leadership believes its shares are undervalued.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $27,000. Vermillion Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $31,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter valued at about $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $32,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.